Role of Bisphosphonates in Breast Cancer Therapy

Keyphrases

• Absolute Benefit 12%
• Absolute Potential 12%
• Adjuvant Bisphosphonates 12%
• Adjuvant Chemotherapy 12%
• Adverse Effects 12%
• Bisphosphonate Treatment 12%
• Bisphosphonates 100%
• Bone Involvement 12%
• Bone Recurrence 12%
• Breast Cancer 12%
• Breast Cancer Mortality 12%
• Breast Cancer Treatment 100%
• Clodronate 12%
• Collaborative Groups 12%
• Cost Reduction 12%
• Current Guidelines 12%
• Distant Recurrence 12%
• Dose-dense 12%
• Early Breast Cancer 25%
• Early Disease 25%
• High Dose 12%
• Hypercalcemia 12%
• Inconsistent Results 12%
• Metastatic Disease 50%
• Nodal Involvement 12%
• Osteolytic Lesions 12%
• Osteonecrosis of the Jaw 12%
• Pain Management 12%
• Performance Status 12%
• Placebo 12%
• Postmenopausal Women 25%
• Potential Gains 12%
• Receptor Status 12%
• Relative Benefit 12%
• Renal Impairment 12%
• Serious Adverse Events 12%
• Skeletal Morbidity 12%
• Skeletal-related Events 12%
• Systemic Therapy 12%
• Treatment Duration 12%
• Treatment Plan 12%
• Treatment-related Adverse Events 12%
• Trialists 12%
• Tumor Grade 12%
• Unselected Patients 12%
• Women-only 12%
• Zoledronic Acid 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Adverse Event 20%
• Bisphosphonic Acid Derivative 100%
• Bone Atrophy 10%
• Breast Cancer 100%
• Cancer Mortality 10%
• Chemotherapy 10%
• Clodronic Acid 10%
• Diseases 10%
• Hypercalcaemia 10%
• Jaw Osteonecrosis 10%
• Neoplasm 10%
• Pamidronic Acid 20%
• Placebo 10%
• Receptor 10%
• Recurrent Disease 20%
• Zoledronic Acid 40%